Related Experiment Videos

Comparative toxicity of mitomycin C and 5-fluorouracil in vitro

S Smith1, P A D'Amore, E B Dreyer

  • 1Laboratory for Surgical Research, Children's Hospital, Boston, Massachusetts.

Insights

5-fluorouracil (5-FU) and mitomycin C (MMC) are used in glaucoma surgery. This study found 5-FU is toxic to fibroblasts but spares vascular cells, while MMC harms both cell types.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Pharmacology

Background:

  • Antimetabolites like 5-fluorouracil (5-FU) and mitomycin C (MMC) are crucial in glaucoma surgery.
  • Their ocular cellular toxicity warrants further investigation, especially regarding vascularity differences in filtering blebs.

Purpose of the Study:

  • To compare the in vitro cellular toxicity of 5-FU and MMC on fibroblasts and capillary endothelial cells.
  • To elucidate differential cellular responses to these antimetabolites in ophthalmic surgery.

Main Methods:

  • Cultured 3T3 fibroblasts and microvascular endothelial cells were exposed to varying doses of 5-FU and MMC.
  • Cell viability and morphology were assessed to determine dose-dependent toxicity.

Main Results:

  • Fibroblasts and capillary endothelial cells exhibited similar sensitivity to MMC.
  • Fibroblasts were significantly more sensitive to 5-FU than endothelial cells.
  • 5-FU demonstrated a selective toxicity profile, sparing vascular endothelial cells.

Conclusions:

  • 5-FU exhibits a favorable toxicity profile for ocular surgery by targeting fibroblasts while sparing vascular endothelial cells.
  • MMC is cytotoxic to both fibroblasts and vascular endothelial cells, potentially explaining observed avascularity in filtering blebs.
  • These findings inform the selection and application of antimetabolites in glaucoma surgical procedures.

Related Concept Videos